Biologics are drugs that require a living organism to manufacture, instead of simply being compounded in a lab. Read on to ...

Shares of Taysha Gene Therapies ended at their highest level in over three years on Thursday after a wave of bullish analyst ...

A free research study at Nebraska Medicine is offering you the chance to learn how your genetics could impact your health.

In a preclinical study, UC Davis Comprehensive Cancer Center scientists developed a highly targeted gene therapy that could revolutionize treatment for cancers linked to a common herpesvirus, with ...

Taysha Gene Therapies stock surges after FDA alignment on a pivotal Rett Syndrome study. Read the latest analysis on TSHA ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $10.33, a high estimate of ...

As September concludes, the landscape of hematologic oncology continues to evolve, spanning the full spectrum of blood cancer ...

With layoffs happening at biopharma companies of all sizes, some may wonder which jobs are safest. Talent acquisition experts ...

Now what this therapy is, is that it's basically a gene knockout therapy, and you give this to the patient via IV route for ...

After years of heartbreak, researchers have found an experimental treatment that can slow the progression of Huntington’s ...

From cancer biology to proactive health management, customized care is changing patient outcomes, but what are the costs and ...

A one-time gene therapy called AMT-130 helped slow the progression of Huntington's disease by 75%, paving the way for the ...